0001209191-18-038415.txt : 20180618 0001209191-18-038415.hdr.sgml : 20180618 20180618182010 ACCESSION NUMBER: 0001209191-18-038415 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180618 FILED AS OF DATE: 20180618 DATE AS OF CHANGE: 20180618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Welles Bernice R CENTRAL INDEX KEY: 0001743779 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35006 FILM NUMBER: 18905651 MAIL ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000831547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930979187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 BUSINESS PHONE: 702-835-6300 MAIL ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 FORMER COMPANY: FORMER CONFORMED NAME: NEOTHERAPEUTICS INC DATE OF NAME CHANGE: 19960819 FORMER COMPANY: FORMER CONFORMED NAME: AMERICUS FUNDING CORP DATE OF NAME CHANGE: 19920703 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2018-06-18 1 0000831547 SPECTRUM PHARMACEUTICALS INC SPPI 0001743779 Welles Bernice R 11500 S. EASTERN AVE. SUITE 240 HENDERSON NV 89052 1 0 0 0 /s/ Kurt A. Gustafson, attorney-in-fact for Bernice R. Welles 2018-06-18 EX-24 2 attachment1.htm EX-24 DOCUMENT

POWER OF ATTORNEY
AUTHORIZATION

I hereby authorize Joseph W. Turgeon, Kurt A. Gustafson and Keith McGahan,
acting singly, to sign and file on my behalf any and all forms required
by the Securities and Exchange Commission pursuant to Section 16 of the
Securities Exchange Act of 1934 (the "Exchange Act") relating to the
reporting of beneficial ownership of equity securities of Spectrum
Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and of
changes in such beneficial ownership, together with any and all
amendments thereto.  This authorization shall be effective on and
after the date set forth below and shall continue in effect until I am
no longer required to file such forms, unless earlier revoked by me in writing.

I acknowledge that the persons authorized hereunder are not assuming, nor
is the Company assuming, any of my responsibilities to comply with
Section 16 of the Exchange Act.

Dated as of this 1st day of June, 2018.

 /s/ Bernice R. Welles, M.D., M.B.A.
Bernice R. Welles, M.D., M.B.A.